Article

Cancer Research in Latin America, 2014-2019, and its Disease Burden

Grant Lewison1★, Gareth I Owen2, Henry Gomez3, Eduardo Cazap4, Raul Murillo5, Karla Unger Saldaña6, Marisa Dreyer7, Audrey Tsunoda8, Jorge Jimenez De La Jara2★ Corresponding author

  1. 1King’s College London, Institute of Cancer Policy, Guy’s Hospital, Great Maze Pond, London, SE1 9RT, UNITED KINGDOM.
  2. 2Pontificia Universidad Católica de Chile, Santiago, Chile; National Cancer Forum of Chile, Santiago, CHILE.
  3. 3Instituto Nacional de Enfermedades Neoplasticas-INEN, Lima 15038, PERU.
  4. 4Latin-American and Caribbean Society of Medical Oncology (SLACOM), Buenos Aires, ARGENTINA.
  5. 5Hospital Universitario San Ignacio, Bogotá, COLOMBIA.
  6. 6CONACYT - Instituto Nacional de Cancerología, Mexico City, MEXICO.
  7. 7Federal University of Rio de Janeiro, Rio de Janeiro, RJ, BRAZIL.
  8. 8Hospital Erasto Gaertner and Pontifícia Universidade Católica do Paraná / PPGTS, Curitiba-PR, BRAZIL.

CORRESPONDENCE

Grant Lewison

King’s College London, Institute of Cancer Policy, Guy’s Hospital, Great Maze Pond, London, SE1 9RT, UNITED KINGDOM.

grantlewison@aol.co.uk

Received: 23-10-2020; Revised: 28-01-2021; Accepted: 06-03-2021.

Volume 10, Issue 1S · pp. s21–s31 · PUBLISHED · DOI: 10.5530/jscires.10.1s.19

View on JSR original site ↗

ABSTRACT

There is little available information on cancer research overall in Latin American and Caribbean countries, and on its relationship with the disease burden from cancer, which is increasing as a proportion of the total. We identified cancer research papers in the Web of Science from 2014-19. Outputs of the region on anatomical cancer sites were compared with the relative disease burden from these cancers. Outputs of individual countries were compared with their wealth and their disease burden from cancer. Their usage and impact on other researchers were determined from U2, a new usage indicator, citation counts over three years (C0-2), and the impact factor of the journals in which they were published (JIF). In 2014-19, Brazil, Chile and Uruguay published twice the amounts expected from the Latin American trend-line, but much less than European countries, relative to their Gross Domestic Products (GDPs). Most countries under-researched cancer relative to its burden. Lung, pancreatic and oesophageal cancers were relatively neglected. Less populous countries’ research was of high impact, principally due to international collaboration with larger nations. Latin American research funding was dominated by the public sector. Current research orientation and funding is insufficient to combat the growing cancer burden in Latin America. This reflects the lack of research funding overall, relative to the countries’ GDPs. The paucity of private-non-profit support needs to be addressed with policies to encourage public donations, and the endowment of foundations. There is also a need to improve the infrastructure for clinical trials.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Lewison, G., Owen, G. I., Gomez, H., Cazap, E., Murillo, R., Saldaña, K. U., Dreyer, M., Tsunoda, A., & Jara, J. J. D. L. (). Cancer Research in Latin America, 2014-2019, and its Disease Burden. Journal of Scientometric Research, 10(1S), s21–s31. https://doi.org/10.5530/jscires.10.1s.19